{
    "2021-04-07": [
        [
            {
                "time": "",
                "original_text": "江苏区域股市周报：13家江苏公司被调研 3.05亿融资净买入江苏股票",
                "features": {
                    "keywords": [
                        "江苏",
                        "调研",
                        "融资净买入"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "地产"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "药明康德(603259)：四季度内生增长提速 客户数和项目数快速增长",
                "features": {
                    "keywords": [
                        "药明康德",
                        "内生增长",
                        "客户数",
                        "项目数"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【权益变动】药明康德(02359-HK)被摩根大通减持45.5846万股 减持股份",
                "features": {
                    "keywords": [
                        "药明康德",
                        "摩根大通",
                        "减持"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "【权益变动】药明康德(02359-HK)获摩根大通增持117.425万股",
                "features": {
                    "keywords": [
                        "药明康德",
                        "摩根大通",
                        "增持"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "大和降药明康德H股目标价18.1%，评级升至买入",
                "features": {
                    "keywords": [
                        "药明康德",
                        "大和",
                        "目标价",
                        "买入"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "中泰国际：重申药明康德(02359)“买入”评级 2020年中国业务引领业绩强势增长",
                "features": {
                    "keywords": [
                        "药明康德",
                        "中泰国际",
                        "买入",
                        "业绩增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "里昂：升药明康德(02359)目标价49%至209.65港元 评级“买入”",
                "features": {
                    "keywords": [
                        "药明康德",
                        "里昂",
                        "目标价",
                        "买入"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药股尾盘回暖，片仔癀大涨7%",
                "features": {
                    "keywords": [
                        "医药股",
                        "尾盘回暖",
                        "片仔癀",
                        "大涨"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "港股盘前必读：深市新主板首日开局平稳，IMF上调中国经济增长至8.4%",
                "features": {
                    "keywords": [
                        "港股",
                        "IMF",
                        "经济增长"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "经济"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "13股获买入评级 最新:药明康德",
                "features": {
                    "keywords": [
                        "买入评级",
                        "药明康德"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}